By Stephanie Brown HealthDay ReporterWEDNESDAY, July 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

D r. James H. Bekker made it clear while standing at a podium in front of the U.S. Food and Drug Administration (FDA) in ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Marty Makary, commissioner of the FDA, is naming George Tidmarsh director of the Center for Drug Evaluation and Research.

Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as ...

George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...